Advanced search
Publication Cover
Postgraduate Medicine Volume 88, 1990 - Issue 1
Submit an article Journal homepage
6
Views
51
CrossRef citations to date
0
Altmetric
AMPHOTERICIN B

Amphotericin B

Still the ‘gold standard’ for antifungal therapy

George A. Sarosi
, MD
Pages 151-166 | Published online: 07 Jul 2016

Citations (51)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Briana L. Scott, Chi D. Hornik & Kanecia Zimmerman. (2020) Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population. Expert Opinion on Drug Metabolism & Toxicology 16:7, pages 605-616.
Read now
Rhonda V. Fleming, Hagop M. Kantarjian, Rola Husni, Kenneth Rolston, Joann Lim, Issam Raad, Sherry Pierce, Jorge Cortes & Elihu Estey. (2001) Comparison of Amphotericin B Lipid Complex (ABLC) vs. AmBisome in the Treatment of Suspected or Documented Fungal Infections in Patients with Leukemia. Leukemia & Lymphoma 40:5-6, pages 511-520.
Read now
John W. Hiemenz & Thomas J. Walsh. (1998) Lipid Formulations of Amphotericin. Journal of Liposome Research 8:4, pages 443-467.
Read now
Graham W Gooday. (1995) Section Review: Anti-infectives: The potential of novel antifungal drugs for the treatment of disease in the immunocompromised host. Expert Opinion on Investigational Drugs 4:8, pages 679-691.
Read now

Articles from other publishers (47)

Elsa R. Arias, Vivian Angarita-Villamizar, Yolima Baena, Claudia Parra-Giraldo & Leon D. Perez. (2021) Phospholipid-Conjugated PEG-b-PCL Copolymers as Precursors of Micellar Vehicles for Amphotericin B. Polymers 13:11, pages 1747.
Crossref
Jinhua Zhang, Hongjiang Xu, Yuanzhen Dong, Minwei Chen, You Zhang, Wenwen Shangguan, Wenjie Zhao & Jun Feng. (2021) Design, synthesis and biological evaluation of a novel N-aminoacyl derivative of amphotericin B methyl ester as an antifungal agent. European Journal of Medicinal Chemistry 211, pages 113104.
Crossref
Angie V. Angarita-Villamizar, Elsa R. Arias, Ivonne L. Diaz & Leon D. Perez. (2021) Amphiphilic copolymers modified with oleic acid and cholesterol by combining ring opening polymerization and click chemistry with improved amphotericin B loading capacity. Journal of Polymer Research 28:1.
Crossref
Yeimy J. Rodriguez, Luis F. Quejada, Jean C. Villamil, Yolima Baena, Claudia M. Parra-Giraldo & Leon D. Perez. (2020) Development of Amphotericin B Micellar Formulations Based on Copolymers of Poly(ethylene glycol) and Poly(ε-caprolactone) Conjugated with Retinol. Pharmaceutics 12:3, pages 196.
Crossref
Thuyen Truong, Guisheng Zeng, Lin Qingsong, Lim Teck Kwang, Cao Tong, Fong Yee Chan, Yue Wang & Chaminda Jayampath Seneviratne. (2016) Comparative Ploidy Proteomics of Candida albicans Biofilms Unraveled the Role of the AHP1 Gene in the Biofilm Persistence Against Amphotericin B. Molecular & Cellular Proteomics 15:11, pages 3488-3500.
Crossref
Grzegorz Czernel, Rafał Typek, Katarzyna Klimek, Aleksandra Czuryło, Andrzej L. Dawidowicz & Mariusz Gagoś. (2016) Catalytic effect of free iron ions and heme-iron on chromophore oxidation of a polyene antibiotic amphotericin B. Journal of Molecular Structure 1111, pages 69-75.
Crossref
Santhanam Shanmughapriya, Haridevvenkatesan Sornakumari, Arumugam Lency, Senthil Kavitha & Kalimuthusamy Natarajaseenivasan. (2014) Synergistic effect of amphotericin B and tyrosol on biofilm formed by Candida krusei and Candida tropicalis from intrauterine device users. Medical Mycology 52:8, pages 853-861.
Crossref
Sarah S.W. Wong, Lakshman P. Samaranayake & Chaminda J. Seneviratne. (2014) In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules. Drug Discovery Today 19:11, pages 1721-1730.
Crossref
Chris Stockmann, Jonathan E. Constance, Jessica K. Roberts, Jared Olson, Elizabeth H. Doby, Krow Ampofo, Justin Stiers, Michael G. Spigarelli & Catherine M. T. Sherwin. (2014) Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications. Clinical Pharmacokinetics 53:5, pages 429-454.
Crossref
Rabkwan Chuealee, Timothy Scott Wiedmann & Teerapol Srichana. (2011) Physicochemical Properties and Antifungal Activity of Amphotericin B Incorporated in Cholesteryl Carbonate Esters. Journal of Pharmaceutical Sciences 100:5, pages 1727-1735.
Crossref
Esther Segal & Daniel Elad. 2010. Topley & Wilson's Microbiology and Microbial Infections. Topley & Wilson's Microbiology and Microbial Infections.
Mehmet Turgut, Yelda ?zsunar, Serkan ?nc?Orhan Aky?z, Mustafa B. Ertu?rul, Cengiz Tekin, Berna G?ltekin & Serhan Sakarya. (2008) Invasive fungal granuloma of the brain caused by Aspergillus fumigatus: a case report and review of the literature. Surgical Neurology 69:2, pages 169-174.
Crossref
Ran D. Goldman, Michael Ong, Jacob Wolpin, Christopher Parshuram, Gideon Koren & John Doyle. (2007) Pharmacological Risk Factors for Amphotericin B Nephrotoxicity in Children. The Journal of Clinical Pharmacology 47:8, pages 1049-1054.
Crossref
Ran D. Goldman & Gideon Koren. (2004) Amphotericin B Nephrotoxicity in Children. Journal of Pediatric Hematology/Oncology 26:7, pages 421-426.
Crossref
Ruta Petraitiene, Vidmantas Petraitis, Caron A. Lyman, Andreas H. Groll, Diana Mickiene, Joanne Peter, John Bacher, Kristin Roussillon, Melissa Hemmings, Derrek Armstrong, Nilo A. Avila & Thomas J. Walsh. (2004) Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits. Antimicrobial Agents and Chemotherapy 48:4, pages 1188-1196.
Crossref
H. Vanden Bossche, M. Engelen & F. Rochette. (2003) Antifungal agents of use in animal health - chemical, biochemical and pharmacological aspects. Journal of Veterinary Pharmacology and Therapeutics 26:1, pages 5-29.
Crossref
Vidmantas Petraitis, Ruta Petraitiene, Andreas H. Groll, Kristin Roussillon, Melissa Hemmings, Caron A. Lyman, Tin Sein, John Bacher, Ihor Bekersky & Thomas J. Walsh. (2002) Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic Rabbits. Antimicrobial Agents and Chemotherapy 46:6, pages 1857-1869.
Crossref
Marianne D. Backer, Walter H. M. L. Luyten & Hugo F. Bossche. 2002. Pathogen Genomics. Pathogen Genomics 167 196 .
Ruta Petraitiene, Vidmantas Petraitis, Andreas H. Groll, Tin Sein, Stephen Piscitelli, Myrna Candelario, Aida Field-Ridley, Nilo Avila, John Bacher & Thomas J. Walsh. (2001) Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia. Antimicrobial Agents and Chemotherapy 45:3, pages 857-869.
Crossref
Samir BouzBouz & Janine Cossy. (2000) Enantioselective Allyltitanation. Efficient Synthesis of the C1−C14 Polyol Subunit of Amphotericin B. Organic Letters 2:25, pages 3975-3977.
Crossref
S.P Vyas, Y.K Katare, V Mishra & V Sihorkar. (2000) Ligand directed macrophage targeting of amphotericin B loaded liposomes. International Journal of Pharmaceutics 210:1-2, pages 1-14.
Crossref
David Goldblum, Beatrice E. Frueh, Stefan Zimmerli & Matthias Böhnke. (2000) Treatment of Postkeratitis Fusarium Endophthalmitis with Amphotericin B Lipid Complex. Cornea 19:6, pages 853-856.
Crossref
Beatriz Luna, Richard H. Drew & John R. Perfect. (2000) Agents for treatment of invasive fungal infections. Otolaryngologic Clinics of North America 33:2, pages 277-299.
Crossref
Ruta Petraitiene, Vidmantas Petraitis, Andreas H. Groll, Myrna Candelario, Tin Sein, Aaron Bell, Caron A. Lyman, Carl L. McMillian, John Bacher & Thomas J. Walsh. (1999) Antifungal Activity of LY303366, a Novel Echinocandin B, in Experimental Disseminated Candidiasis in Rabbits. Antimicrobial Agents and Chemotherapy 43:9, pages 2148-2155.
Crossref
THOMAS J. WALSH, NITA L. SEIBEL, CAROLA ARNDT, RICHARD E. HARRIS, MARK J. DINUBILE, ANNETTE REBOLI, JOHN HIEMENZ & STEPHEN J. CHANOCK. (1999) Amphotericin B lipid complex in pediatric patients with invasive fungal infections. The Pediatric Infectious Disease Journal 18:8, pages 702-708.
Crossref
Liliete Canes Souza & Ana Campa. (1999) Pharmacological parameters of intravenously administered amphotericin B in rats: comparison of the conventional formulation with amphotericin B associated with a triglyceride-rich emulsion. Journal of Antimicrobial Chemotherapy 44:1, pages 77-84.
Crossref
Ihor Bekersky, Robert M Fielding, Donald Buell & Ira Lawrence. (1999) Lipid-based amphotericin B formulations: from animals to man. Pharmaceutical Science & Technology Today 2:6, pages 230-236.
Crossref
Robin Patel. (1998) Antifungal Agents. Part I. Amphotericin B Preparations and Flucytosine. Mayo Clinic Proceedings 73:12, pages 1205-1225.
Crossref
Andreas H. Groll, Stephen C. Piscitelli & Thomas J. Walsh. 1998. 343 500 .
Bruce N. Rogers, Michael E. Selsted & Scott D. Rychnovsky. (1997) Synthesis and biological evaluation of non-polyene analogs of amphotericin B. Bioorganic & Medicinal Chemistry Letters 7:24, pages 3177-3182.
Crossref
C Scully, OP de Almeida & MR Sposto. (2013) The deep mycoses in HIV infection. Oral Diseases 3:S1.
Crossref
Anya M. Hillery. (1997) Supramolecular lipidic drug delivery systems: From laboratory to clinic A review of the recently introduced commercial liposomal and lipid-based formulations of amphotericin B. Advanced Drug Delivery Reviews 24:2-3, pages 345-363.
Crossref
Judith A. Aberg & William G. Powderly. 1996. 215 251 .
M A AmanteaR A BowdenA ForrestP K WorkingM S NewmanR D Mamelok. (1995) Population pharmacokinetics and renal function-sparing effects of amphotericin B colloidal dispersion in patients receiving bone marrow transplants. Antimicrobial Agents and Chemotherapy 39:9, pages 2042-2047.
Crossref
William S. MacLachlan & Simon A. Readshaw. (1995) Stereoselective synthesis of 13-dehydroxy-(14S)-hydroxyamphotericin B methyl ester. Tetrahedron Letters 36:10, pages 1735-1738.
Crossref
George deStevens, V. Zingel, C. Leschke, W. Schunack, Paul D. Hoeprich, Richard M. Schultz, P. K. Mehrotra, Sanjay Batra, A. P. Bhaduri, Anil K. Saxena & Mridula SaxenaPaul D. Hoeprich. 1995. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques 87 127 .
Thomas J. Walsh & Caron A. Lyman. 1995. Infectious Complications of Cancer. Infectious Complications of Cancer 113 148 .
Edward L. Arsura, Yahya Ismail, Sheldon Freedman & Karunakar. (1994) Amphotericin B-induced dilated cardiomyopathy. The American Journal of Medicine 97:6, pages 560-562.
Crossref
Milo? Ot?en??ek & Vladim?r Buchta. (1994) In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens. Mycopathologia 128:3, pages 135-137.
Crossref
Daniel T. Altman, John D. Lubahn & Phyllis J. Kuhn. (1994) A case report and review of mycetoma of the hand: A diagnostic and therapeutic challenge. The Journal of Hand Surgery 19:6, pages 998-1002.
Crossref
Aditya K. Gupta, Daniel N. Sauder & Neil H. Shear. (1994) Antifungal agents: An overview. Part I. Journal of the American Academy of Dermatology 30:5, pages 677-698.
Crossref
S. G. LIM, A. M. SAWYERR, M. HUDSON, J. SERCOMBE & R. E. POUNDER. (2007) Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity. Alimentary Pharmacology & Therapeutics 7:3, pages 317-321.
Crossref
Michael J Driver, Alexander R Greenlees, William S MacLachlan, David T MacPherson & Andrew W Taylor. (1992) Synthesis of 16-decarboxy-16-hydroxymethyl amphotericin B - a novel antifungal agent. Tetrahedron Letters 33:30, pages 4357-4360.
Crossref
Cory Franklin & Michael Metry. (1992) Life-threatening Candida Infections in the Intensive Care Unit . Journal of Intensive Care Medicine 7:3, pages 127-137.
Crossref
V.K. Lepakhin & A.V. Astakhova. 1992. 285 300 .
CHRISTINE L. TERRELL & CAROLYN E. HUGHES. (1992) Antifungal Agents Used for Deep-Seated Mycotic Infections. Mayo Clinic Proceedings 67:1, pages 69-91.
Crossref
R M FieldingP C SmithL H WangJ PorterL S Guo. (1991) Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats. Antimicrobial Agents and Chemotherapy 35:6, pages 1208-1213.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.